News From Our Blog

Image description: Hope is the first baby treated by D-Rev’s Brilliance device in a neonatal care intensive unit in Ogbomoso, Nigeria. He had been diagnosed with severe jaundice and needed an exchange blood transfusion to prevent brain damage or death. Due to the baby’s low birth weight (about 2.6 pounds), a local doctor was unwilling to do an exchange transfusion. After sleeping one night under Brilliance, Hope no longer required a transfusion. Severe neonatal jaundice affects more than 10 percent of newborns and, left untreated, can lead to brain damage and death. The low-energy device uses strategically placed, high-intensity blue LEDs to treat severe jaundice in newborns.
Photo credit: Ben Cline, D-Rev neonatal jaundice project manager/United States Agency for International Development

Image description: Hope is the first baby treated by D-Rev’s Brilliance device in a neonatal care intensive unit in Ogbomoso, Nigeria. He had been diagnosed with severe jaundice and needed an exchange blood transfusion to prevent brain damage or death. Due to the baby’s low birth weight (about 2.6 pounds), a local doctor was unwilling to do an exchange transfusion. After sleeping one night under Brilliance, Hope no longer required a transfusion. Severe neonatal jaundice affects more than 10 percent of newborns and, left untreated, can lead to brain damage and death. The low-energy device uses strategically placed, high-intensity blue LEDs to treat severe jaundice in newborns.

Photo credit: Ben Cline, D-Rev neonatal jaundice project manager/United States Agency for International Development